Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
2001.
Current Awareness.
Pharmacoepidemiology and Drug Safety,
Vol. 10,
Issue. 6,
p.
561.
Chengappa, KN Roy
Gershon, Samuel
and
Levine, Joseph
2001.
The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.
Bipolar Disorders,
Vol. 3,
Issue. 5,
p.
215.
Roy Chengappa, K. N.
Levine, J.
Rathore, D.
Parepally, H.
and
Atzert, R.
2001.
Efectos a largo plazo del topiramato sobre la inestabilidad del estado de ánimo bipolar, el cambio de peso y el control glucémico: una serie clínica.
European psychiatry (Ed. Española),
Vol. 8,
Issue. 6,
p.
361.
Hatahet, M. Ammar
and
Dhurandhar, Nikhil V.
2002.
Antiobesity drugs: Current and future issues.
Current Diabetes Reports,
Vol. 2,
Issue. 5,
p.
409.
Sheth, Raj D.
2002.
Adolescent Issues in Epilepsy.
Journal of Child Neurology,
Vol. 17,
Issue. 2_suppl,
p.
2S23.
Post, Robert M
Speer, Andrew M
Obrocea, Gabriela V
and
Leverich, Gabriele S
2002.
Acute and prophylactic effects of anticonvulsants in bipolar depression.
Clinical Neuroscience Research,
Vol. 2,
Issue. 3-4,
p.
228.
Petrie, John R
and
Perry, Colin G
2002.
Insulin-sensitising agents: beyond thiazolidinediones.
Expert Opinion on Emerging Drugs,
Vol. 7,
Issue. 1,
p.
165.
KLAUER, JANA
and
ARONNE, LOUIS J.
2002.
Managing Overweight and Obesity in Women.
Clinical Obstetrics and Gynecology,
Vol. 45,
Issue. 4,
p.
1080.
Brown, Rex O.
Orr, Carla D.
Hanna, Debra L.
Williams, John E.
and
Dickerson, Roland N.
2002.
Topiramate and Weight Loss in Patients with Neurodevelopmental Disabilities.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy,
Vol. 22,
Issue. 7,
p.
831.
Edwards, Keith R.
Potter, Doreen L.
Wu, Shu-Chen
Kamin, Marc
and
Hulihan, Joseph
2003.
Topiramate in the Preventive Treatment of Episodic Migraine: A Combined Analysis From Pilot, Double-Blind, Placebo-Controlled Trials.
CNS Spectrums,
Vol. 8,
Issue. 6,
p.
428.
Zimmermann, Ulrich
Kraus, Thomas
Himmerich, Hubertus
Schuld, Andreas
and
Pollmächer, Thomas
2003.
Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients.
Journal of Psychiatric Research,
Vol. 37,
Issue. 3,
p.
193.
Uddin, A.B.M. Salah
2003.
Drug-Induced Pseudotumor Cerebri.
Clinical Neuropharmacology,
Vol. 26,
Issue. 5,
p.
236.
Biton, Victor
2003.
Effect of Antiepileptic Drugs on Bodyweight.
CNS Drugs,
Vol. 17,
Issue. 11,
p.
781.
Generali, Joyce
and
Cada, Dennis J.
2003.
Topiramate: Weight Loss (Antipsychotic-Agent-Induced Weight Gain or Obesity).
Hospital Pharmacy,
Vol. 38,
Issue. 4,
p.
328.
Generali, Joyce
and
Cada, Dennis J.
2003.
Topiramate: Binge Eating Disorder.
Hospital Pharmacy,
Vol. 38,
Issue. 12,
p.
1133.
Boro, Alexis
and
Haut, Sheryl
2003.
Medical comorbidities in the treatment of epilepsy.
Epilepsy & Behavior,
Vol. 4,
Issue. ,
p.
2.
McIntyre, Roger S.
Konarski, Jakub Z.
and
Yatham, Lakshmi N.
2004.
Comorbidity in bipolar disorder: a framework for rational treatment selection.
Human Psychopharmacology: Clinical and Experimental,
Vol. 19,
Issue. 6,
p.
369.
Appolinario, Jose C
Bueno, Jo??o R
and
Coutinho, Walmir
2004.
Psychotropic Drugs in the Treatment of Obesity.
CNS Drugs,
Vol. 18,
Issue. 10,
p.
629.
Cross, J. H.
2004.
The Treatment of Epilepsy.
p.
515.
Schwartz, T. L.
Nihalani, N.
Virk, S.
Jindal, S.
and
Chilton, M.
2004.
Psychiatric medication‐induced obesity: treatment options.
Obesity Reviews,
Vol. 5,
Issue. 4,
p.
233.
Comments
No Comments have been published for this article.